A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia

SIMPLE SUMMARY: In spite of the recent expansion of the therapeutic landscape for acute myeloid leukemia (AML), resistance mechanisms and relapsed disease still pose a serious barrier to achieve curation for most patients. Considering the high inter- and intrapatient heterogeneity, disruptive therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbó, José M., Cornet-Masana, Josep M., Cuesta-Casanovas, Laia, Delgado-Martínez, Jennifer, Banús-Mulet, Antònia, Clément-Demange, Lise, Serra, Carme, Catena, Juanlo, Llebaria, Amadeu, Esteve, Jordi, Risueño, Ruth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047683/
https://www.ncbi.nlm.nih.gov/pubmed/36980800
http://dx.doi.org/10.3390/cancers15061912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047683/
https://www.ncbi.nlm.nih.gov/pubmed/36980800
http://dx.doi.org/10.3390/cancers15061912

Ejemplares similares